Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 2
2019 4
2020 5
2021 9
2022 11
2023 12
2024 16
2025 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.
Kahraman S, Erul E, Gumusay O, Guven DC, Aksoy S, Basaran G, Seyyar M, Sahin E, Cabuk D, Bayram E, Paydas S, Demirel BC, Yaren A, Gulbagci B, Hacibekiroglu I, Baytemur NK, Demirci U, Davarci SE, Demir H, Mocan EE, Dogan O, Cilbir E, Yasar A, Bayoglu IV, Hizal M, Kayikcioglu E, Cetin B, Acar O, Erdogan AP, Keskinkilic M, Yavuzsen T, Unal OU, Yilmaz F, Dogan M, Orhan SO, Cubukcu E, Erol C, Sakalar T, Dulgar O, Karakas Y, Ozkanli G, Duman BB, Isik D, Karaoglanoglu M, Okutur SK, Yildirim N, Aydin E, Uluc BO, Keser M, Bilgin B, Aksoy A, Eren O, Kalkan NO, Er MM, Yucel H, Sunar V, Paksoy N, Aydin D, Turhal NS, Menekse S, Kut E, Aykan MB, Ozdemir O, Ozcelik M, Iriagac Y, Selcukbiricik F, Inal A, Karadurmus N, Akinci MB, Sendur MAN. Kahraman S, et al. Among authors: sakalar t. Clin Breast Cancer. 2025 Jul;25(5):e635-e644. doi: 10.1016/j.clbc.2025.03.003. Epub 2025 Mar 4. Clin Breast Cancer. 2025. PMID: 40190010
Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study.
Majidova N, Arak H, Ozalp FR, Bas O, Koker GO, Ozmarasalı EB, Karateke YS, Sakalar T, Yaslikaya S, Onur ID, Akdag G, Ogul A, Guliyev M, Sahin E, Delipoyraz EE, Alkan A, Aydın O, Ilhan N, Alan O, Akbas S, Cağlar Y, Guren AK, Sever N, Ellez HI, Selcukbiricik F, Muhammed Atcı M, Bilici A, Demirci NS, Basoglu T, Karacin C, Kara IO, Yıldız B, Evrensel T, Karaca M, Dizdar O, Atag E, Ozgun A, Kostek O. Majidova N, et al. Among authors: sakalar t. Sci Rep. 2025 Jan 25;15(1):3200. doi: 10.1038/s41598-025-87553-z. Sci Rep. 2025. PMID: 39863702 Free PMC article.
Major and minor salivary gland cancers: A multicenter retrospective study.
Hacioglu MB, Erdogan B, Bardakcı M, Algın E, Gulbagcı B, Hacibekiroglu I, Hamdard J, Olmez OF, Akkus H, Oksuzoglu B, Goksu SS, Dae SA, Sumbul AT, Ugraklı M, Karaagac M, Sahin E, Cabuk D, Ozer O, Yavuzsen T, Arıkan R, Köstek O, Atcı MM, Sakin A, Deligonul A, Bayır D, Dincer M, Unsal O, Yazıcı O, Zeynelgil E, Gulmez A, Harputluoglu H, Erol C, Sendur MAN, Aytekin A, Akagunduz B, Oner I, Er O, Oztosun B, Gumus M, Selçukbiricik F, Aykan MB, Karadurmus N, Degerli E, Demirci NS, Turkmen E, Şakalar T, Secmeler S, Tanrıverdi O, Alkan A, Kemal Y, Cil I, Unal C, Iriagaç Y, Alan O, Balli S, Urun Y, Ozcan E, Turhal NS, Cicin I. Hacioglu MB, et al. Among authors: sakalar t. Head Neck. 2023 Jul;45(7):1643-1653. doi: 10.1002/hed.27376. Epub 2023 Apr 21. Head Neck. 2023. PMID: 37084179
Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG).
Majidova N, Yaslıkaya S, Mıldanoglu MM, Coskun A, Ercan Uzundal D, Sahin TK, Akyildiz A, Akbas S, Camanlı U, Sahin E, Atacan H, Bayrakcı I, Sakalar T, Mordag Cicek C, Gunenc D, İlhan N, Unal OU, Alan O, Hamitoglu B, Ozen Engin E, Sever N, Guren AK, Unsal A, Araz M, Erdogan B, Aykan MB, Selcukbiricik F, Guven DC, Ozdemir N, Sahin AB, Bilici A, Kara IO, Yalcın S, Kostek O. Majidova N, et al. Among authors: sakalar t. Turk J Gastroenterol. 2025 Apr 7;36(5):293-301. doi: 10.5152/tjg.2025.24784. Turk J Gastroenterol. 2025. PMID: 40241388 Free PMC article.
Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study.
Dülgar Ö, Türker S, Başaran G, Araz M, Sümbül AT, Çağlayan D, Gümüşay Ö, Biter S, Konca A, Özen M, Demir H, Özdemir M, Karataş F, Şahin E, Çavdar E, Yasin Aİ, Yaşar A, Derin S, Pehlivan M, Üyetürk Ü, Özdemir Ö, Kayıkçıoğlu E, Ak N, Şakalar T, Sakin A, Büyükşimşek M, Ay S, Ertürk İ, Akbaş S, Bir Yücel K, Gümüş M. Dülgar Ö, et al. Among authors: sakalar t. J Chemother. 2025 Jul;37(4):334-340. doi: 10.1080/1120009X.2024.2366683. Epub 2024 Jun 21. J Chemother. 2025. PMID: 38904164
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer.
Kahraman S, Erul E, Seyyar M, Gumusay O, Bayram E, Demirel BC, Acar O, Aksoy S, Baytemur NK, Sahin E, Cabuk D, Basaran G, Paydas S, Yaren A, Guven DC, Erdogan AP, Demirci U, Yasar A, Bayoglu İV, Hizal M, Gulbagci B, Paksoy N, Davarci SE, Yilmaz F, Dogan O, Orhan SO, Kayikcioglu E, Aytac A, Keskinkilic M, Mocan EE, Unal OU, Aydin E, Yucel H, Isik D, Eren O, Uluc BO, Ozcelik M, Hacibekiroglu I, Aydiner A, Demir H, Oksuzoglu B, Cilbir E, Cubukcu E, Cetin B, Oktay E, Erol C, Okutur SK, Yildirim N, Alkan A, Selcukbiricik F, Aksoy A, Karakas Y, Ozkanli G, Duman BB, Aydin D, Dulgar O, Er MM, Teker F, Yavuzsen T, Aykan MB, Inal A, Iriagac Y, Kalkan NO, Keser M, Sakalar T, Menekse S, Kut E, Bilgin B, Karaoglanoglu M, Sunar V, Ozdemir O, Turhal NS, Karadurmus N, Yalcin B, Sendur MAN. Kahraman S, et al. Among authors: sakalar t. Future Oncol. 2023 Mar;19(10):727-736. doi: 10.2217/fon-2022-1287. Epub 2023 May 3. Future Oncol. 2023. PMID: 37133230
Merkel cell carcinoma in Turkey: A multicentric study.
Yildiz F, Demirci U, Küçükarda A, Büyüksimsek M, Sakalar T, Topcu TO, Aslan F, Tufan G, Aydin O, Turna H, Babacan NA, Basoglu T, Kurt B, Yildiz B, Eren T, Demiray AG, Gumusay O, Arslan C, Özdemir N, Urun Y, Baykara M, Turan N, Uysal M, Bilici A, Kavgaci H, Çiçin İ, Kilickap S, Paydas S. Yildiz F, et al. Among authors: sakalar t. J Cancer Res Ther. 2021 Oct-Dec;17(6):1525-1529. doi: 10.4103/jcrt.JCRT_950_19. J Cancer Res Ther. 2021. PMID: 34916389 Free article.
First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer.
Aktürk Esen S, Ergun Y, Erol C, Arikan R, Er MM, Atci MM, Topçu A, Uçar G, Akagündüz B, Aykan MB, Özen M, Baytemur NK, Özçelik M, Şahin E, Güven D, Menekşe S, Ak N, Teker F, Kut E, Şakalar T, Alan Ö, Kaçan T, Turhal NS, Kiliçkap S, Türker S, Şendur MAN, Köstek O, Karaağaç M, Sakin A, Türk HM, Çağlayan D, Cihan Ş, Açikgöz Y, Uncu D. Aktürk Esen S, et al. Among authors: sakalar t. Bosn J Basic Med Sci. 2022 Sep 16;22(5):818-825. doi: 10.17305/bjbms.2021.7069. Bosn J Basic Med Sci. 2022. PMID: 35460397 Free PMC article.
Real-life experience of patients with sarcomatoid renal cell carcinoma: a multicenter retrospective study.
Almuradova E, Basoglu T, Nayir E, Bayram E, Paydas S, Gokmen I, Karakaya S, Oksuzoglu B, Erdem D, Sakin A, Atcı M, Belen Gulbagcı B, Hacibekiroglu I, Onder AH, Karaarslan S, Karakurt Eryılmaz M, Korkmaz M, Yazıcı O, Sutcuoglu O, Akagunduz B, Arak H, Sakalar T, Aydin D, Iriagac Y, Alan O, Midik M, Cetin D, Kip AD, Turhal S, Kacan T, Koseci T. Almuradova E, et al. Among authors: sakalar t. Neoplasma. 2023 Feb;70(1):158-165. doi: 10.4149/neo_2022_221004N984. Epub 2023 Jan 9. Neoplasma. 2023. PMID: 36620878
65 results